+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Allergic Rhinitis Global Clinical Trials Review, H2, 2019

  • ID: 4655609
  • Clinical Trials
  • December 2019
  • Region: Global
  • 897 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • AstraZeneca Plc
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • Mylan NV
  • Novartis AG
  • Sanofi
  • MORE
Allergic Rhinitis Global Clinical Trials Review, H2, 2019

Summary

The clinical trial report, “Allergic Rhinitis Global Clinical Trials Review, H2, 2019 provides an overview of Allergic Rhinitis clinical trials scenario. This report provides top line data relating to the clinical trials on Allergic Rhinitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using the proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AstraZeneca Plc
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • Mylan NV
  • Novartis AG
  • Sanofi
  • MORE
  • Report Guidance
  • Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Allergic Rhinitis to Respiratory Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Allergic Rhinitis to Respiratory Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Allergic Rhinitis Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Allergic Rhinitis
  • Nov 26, 2019: Marinomed Biotech AG: Detailed clinical data show rapid onset of action of Budesolv to alleviate hay fever
  • Nov 08, 2019: ALK to present new phase 3 data demonstrating the efficacy and safety of Ragwitek (short ragweed pollen allergen extract tablet for sublingual use 12 Amb a 1-U) Sublingual Allergy Immunotherapy (SLIT)-Tablets in pediatric patients at ACAAI 2019 Annual Scientific Meeting
  • Clinical Trial Profile Snapshots
Appendix
  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About the Author
  • Contact Us
  • Source
List of Tables
  • Allergic Rhinitis Therapeutics, Global, Clinical Trials by Region, 2019*
  • Allergic Rhinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Allergic Rhinitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, North America, Top Countries, 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019*
  • Proportion of Allergic Rhinitis to Respiratory Clinical Trials, G7 Countries (%), 2019*
  • Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Allergic Rhinitis to Respiratory Clinical Trials, E7 Countries (%), 2019*
  • Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • Allergic Rhinitis Therapeutics, Global, Clinical Trials by Phase, 2019*
  • Allergic Rhinitis Therapeutics, Global, Clinical Trials In Progress by Phase 2019*
  • Allergic Rhinitis Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Allergic Rhinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*
List of Figures
  • Allergic Rhinitis Therapeutics, Global, Clinical Trials by Region (%), 2019*
  • Allergic Rhinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Allergic Rhinitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, North America, Top Countries (%), 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019*
  • Proportion of Allergic Rhinitis to Respiratory Clinical Trials, G7 Countries (%), 2019*
  • Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Allergic Rhinitis to Respiratory Clinical Trials, E7 Countries (%), 2019*
  • Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • Allergic Rhinitis Therapeutics, Global, Clinical Trials by Phase (%), 2019*
  • Allergic Rhinitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2019*
  • Allergic Rhinitis Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Allergic Rhinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Allergic Rhinitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*
  • Methodology
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • UCB SA
  • Sanofi
  • Novartis AG
  • The Lundbeck Foundation
  • AstraZeneca Plc
  • Mylan NV
  • Teva Pharmaceutical Industries Ltd
  • Dr. Reddy's Laboratories Ltd
Note: Product cover images may vary from those shown
Adroll
adroll